United States Retinal Surgery Devices Market Report by Product, Application, End User, State and Companies Analysis 2026-2034

United States Retinal Surgery Devices Market Size & Forecast 2026-2034

The United States market for retinal surgery devices is projected to register a steady growth rate, advancing from a value of US$ 902.54 million in 2025 to US$ 1,852.87 million by 2034, while recording a Compound Annual Growth Rate (CAGR) of 8.32% between 2026-2034. The growth of this market is driven by the rise in the incidence of retinal diseases, the growing geriatric population, the prevalence of diabetes, and the large adoption rate for advanced surgical technology in hospitals and retinal centers.

United States Retinal Surgery Devices Market Report

The United Devices for retinal surgery are specialized medical instruments and equipment utilized in diagnosing and treating various disorders related to the retina. The retina is the light-sensitive tissue present in the posterior portion of the human eye. It plays a crucial role in vision. Devices utilized in retinal surgery include vitrectomy instruments, retinal lasers, probes with illumination capabilities, microsurgical instruments, and highly advanced imaging systems. Such devices have proven extremely useful in various retinal surgeries related to retinal detachment, diabetic retinopathy, macular holes, and age-related macular degeneration.

The retinal surgery devices market in the United States is experiencing rapid growth, owing to the high prevalence of retinal diseases in the country, in addition to the well-developed healthcare facilities available in the region. The large elderly population, as well as the increasing number of diabetes cases, in the United States form a significant contributing factor for the growing demand for retinal surgery assistance. Also, easy access to advanced ophthalmic services, together with the high adoption of technologically advanced medical solutions and the support of reimbursements, are contributing to the growth of the retinal surgery devices market in the country, further establishing the United States as one of the leading developed markets for retinal surgery devices in the global scenario.

Growth Factor in the United States Retinal Surgery Devices Market

Increasing Prevalence of Retinal Disorders in the United States

Rising cases of retinal diseases act as a key driving factor for the growth of the United States retinal surgery devices market. Issues such as diabetic retinopathy, retinal detachment, macular holes, and age-related macular degeneration are swiftly becoming increasingly common due to a rising pool of diabetics and aging individuals across the country. The United States has one of the largest proportions of diabetics, and this has further fueled the need for advanced retinal surgeries. Early screening and better diagnostic facilities have translated into greater detection rates, thus boosting surgical volumes. As a result, with earlier detection, demands for minimally invasive and highly accurate retinal surgery devices have shot up, with hospitals and eye care facilities investing extensively in advanced facilities such as vitrectors, lasers, and microsurgical equipment to cater to this rising need. The numbers within the aging demographic rise, the incidence of age-related macular degeneration (AMD), set to see 288 million globally to be diagnosed with AMD by the end of 2040, with already 20 million suffering in the US, persists as a threat. However, when this condition leads to geographic atrophy (GA), this accounts for some 20% of all cases of legal blindness in the US alone. Next would be the consideration of inherited retinal diseases (IRDs), which are increasingly being identified owing to enhanced diagnostics and trials in this area. In one study where a US-based electronic health records system was employed, overall prevalence of IRDs emerged at a rate of 106 per 100,000 by the end of 2023, with incidence rising from 12.5 to 15.5 per 100,000 during the same interval. However, next-generation sequencing has caused a sea change in diagnostic capacity, counseling, and trials therefrom for this disease group.

Fast-Paced Technological Developments in Retinal Surgery

Constant innovation in retinal surgery equipment is propelling the market growth in the United States at a rapid rate. Contemporary vitrectomy equipment enables faster cutting, improved fluid dynamics, and greater safety. Technological advancements in imaging equipment, such as high-definition and 3D imaging systems, have enhanced the accuracy of surgery. U.S. doctors readily accept new technologies due to a high degree of active medical research and advanced medical infrastructure. The manufacturers keep on innovating new equipment to cater to changing medical needs and induce hospitals to replace their outdated equipment with advanced equipment. In September 2023, Bausch + Lomb introduced a line of Lumify Eye Illuminations products that are hypoallergenic in nature and contain micellar cleansing water,lash & brow serum, and a hydra-gel brightening cream in their portfolio that has garnered over 15,000 applications.

Strong Healthcare Infrastructural Base and Favourable Reimbursement

The United States has an advanced healthcare infrastructure that facilitates the adoption of advanced retinal surgical devices. The healthcare system in the country offers robust reimbursement coverage for all types of retinal surgeries, thereby encouraging hospitals and surgical centers to invest in the purchase of highly-priced surgical equipment. The availability of special eye care centers and well-experienced retinal surgeons helps the market grow in the country. Moreover, the country spends extensively on healthcare, thereby offering access to advanced care for the retina. For example, in the year 2024, the group EssilorLuxottica contributed $300,000 to the AAOF's OD/PhD Scholarship Fund, to assist optometrists with the goal of meeting the demands for PhD-trained faculty members and to advance the education of vision care. All these contribute to the growing need for more adequate human resources to handle the complexities associated with eye care.

Challenge in the United States Retinal Surgery Devices Market

High Cost of Retinal Surgery Devices

Despite the technological advancements, the expense associated with the equipment used for the surgery remains a significant challenge for the industry. It requires heavy capital expenditures for advanced vitrectomy systems, lasers, and imaging equipment. Small practices and day surgery centers may also experience budget limitations when it comes to the acquisition and usage of the most advanced equipment. It also incurs expenses associated with consumable products, maintenance, and training of personnel.

Shortage of Skilled Retinal Surgeons

Retinal surgery needs extremely skilled personnel, and scarcity of trained retinal specialists may create a hurdle. Advanced surgery equipment requires necessary training to ensure optimal results. Less access to trained surgeons may hamper regions that are not fully utilizing the growing base of patients due to the rising prevalence of the disease.

United States Retinal Surgery Vitrectomy Packs Devices Market

A vitrectomy pack is a crucial part of retinal surgery kits. These are used to provide a sterile single use kit that helps in the retinal surgery procedure. The market in the United States is propelled by the rise in the number of retinal procedures being conducted. Additionally, the need for infection control is another factor that is increasing the demand for vitrectomy disposable kits. Additionally, the rise in the cases of retinopathy has fueled the retinal surgery kits market.

United States Retinal Surgery Instruments Market

The devices used in retinal surgery include forceps, scissors, cannulas, lighting probes, and laser devices. The need for precise devices is rising, associated with the rising complexity of retinal surgery. American surgeons prefer ergonomically designed devices, which help increase control and minimize injury to tissues. Innovation in devices is fueling the growth of the market.

United States Diabetic Retinopathy Surgery Devices Market

Diabetic retinopathy has emerged as a leading cause of blindness in the USA. Increasing prevalence of diabetes and better screening facilities have led to an increase in surgical procedures. Advanced vitrectomy equipment and laser equipment have found wide application in the treatment of more advanced cases. The segment remains on the growth mold even now.

United States Retinal Detachment Surgery Devices Market

Retinal Detachment is an urgent operation that demands high and continuous use of retinal surgery equipment. Vitrectomy equipment, laser photocoagulation equipment, and cryotherapy units are the main used devices. Increased awareness among many is contributing to steady market growth.

US Retinal Surgery Devices Hospital Market

Hospitals constitute the prominent end-use segment because of the larger patient pool and availability of advanced facilities. Teaching hospitals and multi-specialty centers perform complex retinal surgery, and the demand for advanced devices is driven by these centers. Favorable reimbursement and government support fuel the demand.

United States Retinal Surgery Devices Eye Clinics Market

Specialty eye centers are increasingly adopting retinal surgical devices due to patient preference for ambulatory surgery. Eye centers tend to emphasize streamlined processes, reducing waiting times, and specialized care, which stimulates demand for miniaturized advanced surgical systems.

California Retinal Surgical Devices Market

California is one of the biggest markets for retinal surgery equipment in the United States. This is due to favorable factors such as a huge number of inhabitants, a sophisticated healthcare infrastructure, and a high rate of retinal disorders. The region also has a high percentage of older patients. Furthermore, it also has a high rate of diabetes, with a consequent increase in patients with diabetic retinopathy, retinal detachment, and macular diseases. The highest quality medical institutions, vitreoretinal surgery hospitals, and ambulatory surgery centers in the US can be found in the region. They aggressively promote the adoption of advanced retinal surgery equipment. High medical spending, early adoption of advanced minimally invasive vitrectomy equipment, and innovation-driven growth also promote growth of the medical equipment market. Notably, the presence of prominent medical equipment manufacturers and technology developers in the region also stimulates the rapid development and commercialization of new equipment in retinal surgery. Widely available medical insurance coverage and public awareness also stimulate the adoption of advanced equipment in retinal surgery across hospitals and vitreoretinal surgery centers in the region. Apr 2025, Alcon declared the commercial availability of the company's latest range of surgical equipment products: the 'UNITY Vitreoretinal Cataract System' with a catalog number of 'VCS' commercial version and the 'UNITY Cataract System' with a catalog number 'CS' commercial version. FDA approved in June 2024, these products fall into a series of sophisticated equipment products known as Alcon 'Vision Suite', originally developed by a prominent medical equipment developer. This equipment development involves the merging of vitreoretinal surgery and cataract surgery indications. This equipment consists of a combined vitreoretinal surgery and cataract surgery-based indication equipment with a combined 'console' with a catalog number 'VSC' and a standalone 'Cataract System' 'CS' equipment.

New York Retinal Surgery Devices Market

New York represents an established all-makes surgical system market for the retina, fueled by the availability of large patient populations as well as the extensive coverage of academic medical institutions and speciality eye care facilities." With an aging population and an increased number of patients suffering from chronic conditions like diabetes, the state witnesses robust demand for retina surgical procedures. In New York, the institution's reputation and patient loyalty fuel the market for retina surgical systems." Academic medical institutions and speciality eye care facilities in the state contribute remarkably towards the adoption of latest retina surgical systems and technologies like "fast vitrector systems and advanced visualization." Also, the favorable healthcare policies and increased availability of speciality eye care facilities add towards the growing acceptance of retina surgical systems. In August of this year, BVI Medical officially launched the ISPANTM brand of ophthalmic gases." This represents the "first ever launch of the company into the US market for the retina gas products." This also symbolizes another milestone in the growing progress of BVI at an ever-increasing pace. Recently, the company obtained approval from the FDA for the revolutionary laser and endoscopic glaucoma surgical system 'Leos.' The company itself started out from the 'cataract side of the ophthalmology market.

New Jersey Retinal Surgery Devices Market

New Jersey exhibits a significant and increasing trend in the retinal surgery devices market, owing to the high healthcare expenditure and proximity to large medical institutions in the northeastern part of the USA. There are large numbers of hospitals, ambulatory surgery centers, and specialized eye care practices in the state. The increasing numbers of diabetic and age-related retinal diseases are also contributing to the demand for vitrectomy equipment, retinal lasers, and microsurgical instruments. New Jersey also shares strong ties with the pharmaceutical and medical device industries, ensuring early adoption and availability of innovative retinal technologies. Good insurance coverage and patient education programs also promote early treatment and management of retinal diseases. Thus, the retinal surgery devices market in New Jersey also exhibits significant and consistent growth. July 10, 2025 - MMI, a robotics company focused on advancing the care of the most complicated patients by broadening the possibilities offered by robotics, today announced the first clinical use of two new technologies that amplify the possibilities offered by robotics-assisted microsurgery: the NanoWrist dissection instruments and the Synaptix Digital Surgery Platform.

Texas Retinal Surgery Devices Market

Terry W Texas is among the most rapidly expanding markets for the use of retinal surgery devices in the United States, due to the rapid population growth, and the rising number of senior citizens and cases of diabetes. There are many hospitals and specialized eye care facilities located throughout the largest cities, including Houston, Dallas, and Austin, which provide the support for an increased base of surgical procedures for the retina. There is a growing need for more advanced vitrectomy and minimally invasive surgical instruments, as the focus continues to turn toward optimizing outcomes and efficiency. Alcon, with headquarters in Fort Worth, TX, received FDA 510(k) marketing clearance for the UNITY line of products in June 2024. The new device has greater cut rates and a more optimized fluidics system, which enhances surgical efficiency.

Market Segmentations

Product

• Vitrectomy Machines
• Vitrectomy Packs
• Surgical Instruments
• Microscopic Illumination Equipment
• Retinal Laser Equipment
• Others

Application

• Diabetic Retinopathy
• Retinal Detachment
• Epiretinal Membrane
• Macular Hole
• Others

End User

• Hospitals
• Eye Clinics
• Others

Top States

• California
• Texas
• New York
• Florida
• Illinois
• Pennsylvania
• Ohio
• Georgia
• New Jersey
• Washington
• North Carolina
• Massachusetts
• Virginia
• Michigan
• Maryland
• Colorado
• Tennessee
• Indiana
• Arizona
• Minnesota
• Wisconsin
• Missouri
• Connecticut
• South Carolina
• Oregon
• Louisiana
• Alabama
• Kentucky
• Rest of United States

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis

• Topcon Corporation
• Alcon AG
• Carl Zeiss
• Bausch Health Companies Inc.
• Iridex Corporation
• Escalon Medicals
• Quantel Medical
• Rhein Medical, Inc